1. Photoactivatable CRISPR/Cas9 System

    Akhmetova, E. A., Golyshev, V. M., Vokhtantcev, I. P., Meschaninova, M. I., Venyaminova, A. G. & Novopashina, D. S., Mar 2021, In: Russian Journal of Bioorganic Chemistry. 47, 2, p. 496-504 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Pharmacokinetic study of Tdp1 inhibitor resulted in a significant increase in antitumor effect in the treatment of Lewis lung carcinoma in mice by its combination with topotecan

    Okhina, A. A., Kornienko, T. E., Rogachev, A. D., Luzina, O. A., Popova, N. A., Nikolin, V. P., Zakharenko, A. L., Dyrkheeva, N. S., Pokrovsky, A. G., Salakhutdinov, N. F. & Lavrik, O. I., 30 Nov 2023, In: Journal of Pharmaceutical and Biomedical Analysis. 236, 9 p., 115731.

    Research output: Contribution to journalArticlepeer-review

  3. PARPs’ impact on base excision DNA repair

    Lavrik, O. I., Sept 2020, In: DNA Repair. 93, 6 p., 102911.

    Research output: Contribution to journalReview articlepeer-review

  4. PARP1 Regulates the Biogenesis and Activity of Telomerase Complex Through Modification of H/ACA-Proteins

    Savelyev, N. V., Shepelev, N. M., Lavrik, O. I., Rubtsova, M. P. & Dontsova, O. A., 19 May 2021, In: Frontiers in Cell and Developmental Biology. 9, 621134.

    Research output: Contribution to journalArticlepeer-review

  5. PARP1, PARP2 and PARP3 interaction with nucleosomes containing DNA-lesions

    Kurgina, T. A., Kutuzov, M. M., Belousova, E. A., Ukraitsev, A. A., Anarbaev, R. O. & Lavrik, O. I., Jul 2021, In: FEBS Open Bio. 11, p. 244-245 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  6. PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA

    Singatulina, A. S., Hamon, L., Sukhanova, M. V., Desforges, B., Joshi, V., Bouhss, A., Lavrik, O. I. & Pastré, D., 7 May 2019, In: Cell Reports. 27, 6, p. 1809-1821.e5 18 p.

    Research output: Contribution to journalArticlepeer-review

  7. Parallel Reaction Monitoring Mode for Atenolol Quantification in Dried Plasma Spots by Liquid Chromatography Coupled with High-Resolution Mass Spectrometry

    Aksenova, L. V., Koval, V. V. & Chernonosov, A. A., Jul 2022, In: Processes. 10, 7, 1240.

    Research output: Contribution to journalArticlepeer-review

  8. Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways

    Zolotovskaia, M. A., Modestov, A. A., Suntsova, M. V., Rachkova, A. A., Koroleva, E. V., Poddubskaya, E. V., Sekacheva, M. I., Tkachev, V. S., Garazha, A. V., Glusker, A. A., Seryakov, A. P., Vladimirova, U. S., Rumiantsev, P. O., Moisseev, A. A., Zharkov, D. O., Kuzmin, D. V., Zhao, X., Prassolov, V. S., Shegay, P. V., Li, X., & 5 othersSteinbichler, T. B., Kim, E., Sorokin, M. I., Wang, Y. & Buzdin, A. A., Mar 2023, In: DNA Repair. 123, 18 p., 103448.

    Research output: Contribution to journalArticlepeer-review

  9. P.0472 Immunoglobulins G hydrolyze recombinant fragments of NMDA receptor NR1 and NR2 subunits in schizophrenia and multiple sclerosis: preliminary results

    Ermakov, E., Kuznitsyna, A., Smirnova, L., Parshukova, D., Surin, A., Boksha, I. & Ivanova, S., Dec 2021, In: European Neuropsychopharmacology. 53, p. S347-S348 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. Oxidative damage to epigenetically methylated sites affects DNA stability, dynamics and enzymatic demethylation

    Gruber, D. R., Toner, J. J., Miears, H. L., Shernyukov, A. V., Kiryutin, A. S., Lomzov, A. A., Endutkin, A. V., Grin, I. R., Petrova, D. V., Kupryushkin, M. S., Yurkovskaya, A. V., Johnson, E. C., Okon, M., Bagryanskaya, E. G., Zharkov, D. O. & Smirnov, S. L., 16 Nov 2018, In: Nucleic Acids Research. 46, 20, p. 10827-10839 13 p.

    Research output: Contribution to journalArticlepeer-review

ID: 3083609